Big congratulations to our very own Foundation director, Professor Brian Dean, who has received the following awards in 2019 recognising the outstanding contribution he has made to basic research in Schizophrenia:
2019 Outstanding Basic Research Award winner by Schizophrenia International Research Society (SIRS)
Lundbeck Basic Science Award from the Asian College of Neuropsychopharmacology (AsCNP)
Prof Dean has published more than 250 Peer-reviewed original research articles and his major research interest aims to understanding the roles of muscarinic receptors, serotonin receptors, cytokine-regulated pathways and changed gene expression in causing, and as potential drug targets for, schizophrenia.
Professor Dean has now reached the point in his career where some of his basic research findings are being translated into the clinic. This is being achieved by collaborations with clinical colleagues and involves the use of a newly synthesised PET muscarinic receptor radioligand to measure brain receptor levels in people with schizophrenia and to use a newly discovered technology to develop a diagnostic test for the disorder.
When Professor Dean applied to the Rebecca L Cooper Medical Research Foundation for an equipment grant as an early-career researcher in 1988, it was clear that we had an outstanding researcher in our midst. He has clearly gone on to prove us right, carving out a career to be proud of and achieving bigger and better awards. The Foundation is fortunate to have Professor Dean’s guidance in steering the Foundation, and especially its funding strategy.
Read more about how the Foundation helped launch Professor Dean’s research career.